Lymphoid Disorders Flashcards
location of B cell maturation
bone marrow
Immunophenotype of B cells
- CD19, CD20, CD10
Immunophenotype of T cells
- CD3, CD4, CD5
Location of B & T cells w/ in the spleen
- cortex = B cells
- paracortex = T cells
Reactive lymphadenitis/lymphadenopathies morphology
- follicular (nodular)
- sinus
- diffuse
- granulomatous
- necrotizing
- mixed
Reactive lymphoid hyperplasia
- most common in children
- lymph nodes: tender, soft, freely movable
- polarized follicles
- tingible body macrophages, high mitotic activity
- Bcl-2 NEGATIVE in germinal centers*
Infectious Mononucleosis Lymphadenitis
- induced by EBV
- primarily effects adolescents
- REED STERNBERG CELLs
- positive monospot test, EBV-specific antigens
- mixed (diffuse/follicular) lymph node pattern
Cat Scratch lymphadenitits
- contact with cats
- unilateral lymphadenitis
- necrotizing granulomas w/ PMN cells
- positive silver stain
Toxoplasma lyphadenitis
- most common parasitic infection in US
- POSTERIOR CERVICAL lymphadenitis
- fetal toxoplasmosis as a result of transplacental infection possible
- IgM>1:80 is diagnostic
- absence of necrosis
Reactive lymphoid hyperplasia Bcl-2 result
RLH the germinal center cells are Bcl-2 NEGATIVE
Children & young adult lymphoid neoplasia
- hodgkin & burkitt lymphomas
Important clinical features of lymphomas
- enlarge, PAINLESS lymphadenopathy
- B symptoms frequent (fever, chills, NIGHT SWEATS)
Lymphoproliferative disorders
lymphoma & leukemia
Lymphomas
Hodgkin & Non-Hodgkin
Most common lymphomas
- Diffuse large B cell lymphoma: 30.6%
- Follicular lymphoma: 22.1%
Follicular lymphoma
- Adults
- asymptomatic LN enlargement
- back to back follicles
- grade1/2 = 15 centroblasts
- 2/3 of patients present with > Stage III disease*
Follicular lymphoma: immunophenotype
- CD10 & Bcl-2 postitive
- Bcl 2 gene rearragement: t(14;18)
Follicular lymphoma summary
- adults: 6th decade
- lymph nodes: firm, mottled, non movable
- no polarization
- no tingible body marcrophages, low mitotic activity
- Bcl 2 positive germinal centers, t(14;18)
Diffuse large B cell lymphoma
- most common type of lymphoma
- clinically aggresive
- potentially curable w/ chemo w/ anti CD20(rituximab) & BMT
- germinal B cell type (GBC) has better prognosis than non GBC type
Burkitt lymphoma/leukemia (BL): features and prognosis
- endemic BL: presents as jaw/orbit masses
- most present with advanced stage
- curable with aggressive chemo
BL - aggressiveness
BL very aggressive: dividing time is 24 hours
BL immunophenotype
- positive for CD10
- negative for Bcl-2
BL cytogenetics
typically t(8:14)
Mantle cell lymphoma (MCL) - features
- older adults w/ M:F ratio of 3:1
- usually is stage III or IV with extranodal involvement
MCL - cytogenetics
- positive for CD5
- t(11:14)
- cyclin D1 (Bcl-1)
Prognosis of MCL
- despite high tumor response to Tx(80-95%) overall survival is 3-4 yrs
- factors: growth pattern, morphology, proliferation index
Marginal Zone lymphoma (MZL)
- indolent
- associated with Helicobacter pylori infection
- Immunophenotype: CD19 & CD20 ONLY**
Morphology of MZL
- scattered large cells are always present
Hodgkin lymphoma: most common type
Nodular sclerotic classic hodgkins lymphoma
Treatment for nodular lymphocyte predominant hodgkins lymphoma
surgery
Stats for NSCHL
- prevelance: 70% (of hodgkins lymphomas)
- age: 28
- M:F ratio 1:1
Clinical features of HL
- responds well to chemo
- CD30, CD15 positive & CD45 negative
HL morphology
Reed-Sternberg cell
Dianosis of HL
- will not diagnose from FNA
HL prevelance
- bimodal age curve showing peak at 15-35 years and second peak after 60 years
Chronic lymphocytic leukemia/small lymphocytic leukemia: lymph findings
- diffuse tissue infiltration by small, round neoplastic lympoctyes
Transformation of CLL/SLL
- CLL/SLL transformation to DLBCL: RICHTER TRANSFORMATION
- decreased survival: 6-8 months
CLL/SLL immunophenotype
- coexpression of CD5, CD23
Most common translocations
- follicular lymphoma: t(14;18) Bcl-2
- burkitt lymphoma: t(8;14) c-MYC
- mantle cell lymphoma: t(11;14) cyclin D1
CLL/SLL immunophenotype
CD5+, CD20+, CD23+
FL immunophenotype
CD10+, CD20+
MCL immunophenotype
CD5+, CD20+
Burkitt immunophenotype
CD10+, CD20+
MZL immunophenotype
CD20+
Location of T cell maturation
- thymus
- undergo negative/positive selection